Furthermore, high expression of VLDLR was associated with poor overall survival and relapse-free survival in breast cancer patients (Figures 6D, E and Supplementary Figures 7B, D), suggesting that VLDLR could be considered as a potential therapeutic target for breast cancer therapy. This evidence concerns the gene VLDLR and breast carcinoma.